Rituximab Combined With Chidamide and Lenalidomide for r/r AITL

NCT04319601 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Angioimmunoblastic T-cell Lymphoma
Chemotherapy Effect
Chemotherapeutic Toxicity

Interventions

DRUG: Rituximab

Sponsor

Zhejiang Cancer Hospital